Consolidated Balance Sheets - USD ($)	Apr. 30, 2020	Jul. 31, 2019
Current Assets
Cash and cash equivalents	$ 1,115	$ 1,850
Total Current Assets	1,115	1,850
TOTAL ASSETS	1,115	1,850
Current Liabilities
Accounts payable and accrued liabilities	65,976	59,582
Due to related parties	192,406	164,706
Convertible notes payable - related party	554,163	371,089
Liabilities from discontinued operation	19,500	19,500
Total Current Liabilities	832,045	614,877
TOTAL LIABILITIES	832,045	614,877
Stockholders' Deficit
Common stock: 300,000,000 authorized; $0.001 par value 79,792,286 shares issued and outstanding at April 30, 2020 and July 31, 2019	79,792	79,792
Additional paid in capital	11,660,263	11,660,263
Accumulated deficit	(12,570,985)	(12,353,082)
Total Stockholders' Deficit	(830,930)	(613,027)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 1,115	$ 1,850

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

Name:	us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.